144 related articles for article (PubMed ID: 36635646)
1. Willingness to pay for cancer prevention, screening, diagnosis, and treatment: a systematic review.
Ben-Aharon O; Iskrov G; Sagy I; Greenberg D
Expert Rev Pharmacoecon Outcomes Res; 2023 Mar; 23(3):281-295. PubMed ID: 36635646
[TBL] [Abstract][Full Text] [Related]
2. Willingness to pay for diagnostic technologies: a review of the contingent valuation literature.
Lin PJ; Cangelosi MJ; Lee DW; Neumann PJ
Value Health; 2013; 16(5):797-805. PubMed ID: 23947973
[TBL] [Abstract][Full Text] [Related]
3. Willingness to pay for an mRNA-based anti-cancer treatment: results from a contingent valuation study in Israel.
Ben-Aharon O; Sergienko R; Iskrov G; Greenberg D
Isr J Health Policy Res; 2024 Feb; 13(1):9. PubMed ID: 38374060
[TBL] [Abstract][Full Text] [Related]
4. Consumers' Willingness to Pay for eHealth and Its Influencing Factors: Systematic Review and Meta-analysis.
Xie Z; Chen J; Or CK
J Med Internet Res; 2022 Sep; 24(9):e25959. PubMed ID: 36103227
[TBL] [Abstract][Full Text] [Related]
5. Determining the Willingness to Pay for Innovative Oncology Medicines in Malaysia.
Dzulkipli MR; Shafie AA; Maon SN; Ramli A; Yahaya AHM; Ho SW; Muhsin NIA; Ahmat ANMF
Value Health Reg Issues; 2024 Mar; 40():19-26. PubMed ID: 37972430
[TBL] [Abstract][Full Text] [Related]
6. Willingness to pay for packaging cancer screening of Chinese rural residents.
Zhang Q; Ren D; Chang X; Sun C; Liu R; Wang J; Zhang N
Cancer Med; 2023 Feb; 12(3):3532-3542. PubMed ID: 36000818
[TBL] [Abstract][Full Text] [Related]
7. Health care contingent valuation studies: a review and classification of the literature.
Diener A; O'Brien B; Gafni A
Health Econ; 1998 Jun; 7(4):313-26. PubMed ID: 9683092
[TBL] [Abstract][Full Text] [Related]
8. Critical review of willingness to pay for clinical oral health interventions.
Tan SHX; Vernazza CR; Nair R
J Dent; 2017 Sep; 64():1-12. PubMed ID: 28662842
[TBL] [Abstract][Full Text] [Related]
9. Willingness-to-pay for a population-based-prostate-specific antigen screening for prostate cancer in Anambra State, Southeast, Nigeria: a contingent valuation study.
Umeh BI; Ogbonna BO; Nduka SO; Nduka JI; Ejie LI; Mosanya UA; Ekwunife IO
Afr Health Sci; 2022 Dec; 22(4):46-55. PubMed ID: 37092074
[TBL] [Abstract][Full Text] [Related]
10. Willingness to pay for HPV vaccine among female health care workers in a Chinese nationwide survey.
Lu X; Ji M; Wagner AL; Huang W; Shao X; Zhou W; Lu Y
BMC Health Serv Res; 2022 Nov; 22(1):1324. PubMed ID: 36335333
[TBL] [Abstract][Full Text] [Related]
11. Determinants of willingness to pay for health services: a systematic review of contingent valuation studies.
Steigenberger C; Flatscher-Thoeni M; Siebert U; Leiter AM
Eur J Health Econ; 2022 Dec; 23(9):1455-1482. PubMed ID: 35166973
[TBL] [Abstract][Full Text] [Related]
12. Husband's willingness-to-pay for HIV and syphilis screening at antenatal care clinic under the Thai universal coverage scheme.
Anunsittichai O; Pongpirul K; Puthanakit T; Roowicha K; Kaewprasert J; Songtaweesin WN; Chaithongwongwattana S
BMC Public Health; 2020 Apr; 20(1):480. PubMed ID: 32276624
[TBL] [Abstract][Full Text] [Related]
13. Examining Willingness-to-Pay and Zero Valuations for a Health Improvement with Logistic Regression.
Mavrodi AG; Chatzopoulos SA; Aletras VH
Inquiry; 2021; 58():469580211028102. PubMed ID: 34271848
[TBL] [Abstract][Full Text] [Related]
14. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
15. Willingness to pay for a National Health Insurance Scheme in The Gambia: a contingent valuation study.
Njie H; Wangen KR; Chola L; Gopinathan U; Mdala I; Sundby JS; Ilboudo PGC
Health Policy Plan; 2023 Jan; 38(1):61-73. PubMed ID: 36300926
[TBL] [Abstract][Full Text] [Related]
16. Estimating Willingness to Pay for an Improved Service Delivery to Patients Referring Namazi Hospital Chemical Therapy Ward in Iran Using Contingent Valuation.
Kavosi Z; Jafari A; Keshtkaran V; Pourahmadi E
Asian Pac J Cancer Prev; 2018 Jul; 19(7):1817-1823. PubMed ID: 30049193
[TBL] [Abstract][Full Text] [Related]
17. Acceptance and willingness to pay under the different COVID-19 vaccines: A contingent valuation method.
Prasert V; Thavorncharoensap M; Vatcharavongvan P
Res Social Adm Pharm; 2022 Nov; 18(11):3911-3919. PubMed ID: 35691798
[TBL] [Abstract][Full Text] [Related]
18. Willingness to pay for the maintenance of equity in a local ivermectin distribution scheme in Toro, Northern Nigeria.
Onwujekwe OE; Shu EN; Okonkwo PO
Public Health; 1999 Jul; 113(4):193-4. PubMed ID: 10483083
[TBL] [Abstract][Full Text] [Related]
19. Evaluating discrete choice experiment willingness to pay [DCE-WTP] analysis and relative social willingness to pay [RS-WTP] analysis in a health technology assessment of a treatment for an ultra-rare childhood disease [CLN2].
Moro D; Schlander M; Telser H; Sola-Morales O; Clark MD; Olaye A; Camp C; Jain M; Butt T; Bakshi S
Expert Rev Pharmacoecon Outcomes Res; 2022 Jun; 22(4):581-598. PubMed ID: 34877915
[TBL] [Abstract][Full Text] [Related]
20. Willingness-to-Accept and Willingness-to-Pay Ratios of Prevention of Mother-to-Child Transmission Services in a Nigerian Hospital: A Cross-Sectional Contingent Valuation Study.
Isah A; Adibe MO; Anosike C; Aluh DO; Onyekwelu PO; Okonta MJ; Ukwe CV
Value Health Reg Issues; 2019 Sep; 19():112-121. PubMed ID: 31404819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
